Delivery Order SPE2DR25D3501-SPE2DR26FL9UK
Award Date 12/2/25
Potential Completion Date 12/23/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,294.40 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Rhophylac 300 mcg/2 mL syringes. This contract represents a firm fixed-price delivery order with an ultimate completion date of October 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively awarded without set-aside designation, reflecting AmerisourceBergen's continued capability to fulfill federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Rhophylac 300 mcg/2 ml syringes in 2 ml quantities. This competitively awarded, non-set-aside contract is valued at $1,388.40 and operates under a firm fixed price structure, with an ultimate completion date of December 19, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Rhophylac 300 mcg/2 mL syringes with a ceiling value of $1,720.80 and a firm fixed price structure. The contract is not set-aside and represents a competitive award to the pharmaceutical distributor. Performance will be completed by October 10, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Rhophylac 300 mcg/2 mL syringes with a ceiling value of $2,868.00 and firm fixed pricing. This delivery order, issued without a set-aside designation, represents a competitively awarded contract supporting federal medical procurement needs. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML medical supplies. The $4,590.10 contract has a performance period through March 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and no set-aside designations were used. This delivery order is part of a larger indefinite delivery contract (IDC)...
- This federal contract award, valued at $1,836.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a prescription medication. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of July 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product. The $1,377.03 firm fixed price delivery order has a completion date of September 23, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- The Defense Logistics Agency awarded a delivery order valued at $2,776.80 to AmerisourceBergen Drug Corp for Rho(D) Immune Globulin (RHOPHYLAC) 300 mcg/2 mL syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of January 13, 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery order is issued under AmerisourceBergen's larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $4,590.10 firm fixed price delivery order is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a specialty pharmaceutical product, in support of military treatment programs and facilities. The award is not set aside and is part of a larger indefinite delivery...
- The Defense Logistics Agency awarded a $2,954.04 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for Rhogam Ultra-Filtered Plus syringes, with an ultimate completion date of July 22, 2025. This non-set-aside contract is being performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and holds an...